HBM Partners carries out an ongoing analysis of all trade sales of public and private US and European biotech and pharma companies. The latest HBM Pharma/Biotech M&A Report as well as information on M&A transactions since 2005 are available for download:

Report covers new drugs approved by US FDA. The latest report as well as a list of new drug approvals since 2003 are available for download.